Stanley Druckenmiller’s portfolio: Duquesne Family Office 13F holdings

Quarterly SEC 13F-HR filingsCIK 0001536411Latest: Q2 2026

Q3 2024 filing in brief

In its Q3 2024 13F, filed November 14, 2024, Duquesne Family Office reported $3.0B across 75 US positions. The largest: NTRA (15.3%), CPNG (9.7%), COHR (9.0%), WWD (6.2%), Seagate Technology Hldngs Pl (6.1%). In the quarter it opened 33 positions, sold out of 22, added to 11 and trimmed 20; positions opened and sold out came to 27.7% of the portfolio's value.

Methodology

Holdings come from the manager’s Form 13F-HR filings on SEC EDGAR, with amendments applied. Values and shares are reported at quarter-end; the filing date is when the report became public. These disclosures show reported long positions and listed options, not the manager’s entire portfolio or its trades since quarter-end.

Quarterly changes compare shares with the immediately preceding quarter on file. New and exited positions appear or disappear; added and trimmed positions change their share count by more than 1%. A share change can also reflect a stock split or other corporate action.

Opened and sold out is the value of new positions plus the prior value of exited positions, divided by the average of the two quarters’ reported portfolio values. It excludes changes to positions still held. Reported value growth includes price changes and is not a measure of investment performance. Largest-five and largest-ten weights exclude options.

Holdings

Filed Nov 14, 2024

  • 33 New
  • 11 Added
  • 20 Trimmed
  • 22 Exited

75 positions at September 30, 2024. Q/Q change compares shares with the preceding quarter.

RowTickerIssuerStatus
1NTRANatera Inc$453M3.6M15.34%+80.6%Added
2CPNGCoupang Inc$287M11.7M9.73%+6.6%Added
3COHRCoherent Corp$265M3.0M8.97%−17.0%Trimmed
4WWDWoodward Inc$181M1.1M6.15%+10.8%Added
5—Seagate Technology Hldngs Pl$180M1.6M6.09%−6.5%Trimmed
6PMPhilip Morris Intl Inc$138M1.1M4.67%+27.6%Added
7KRESpdr Ser Tr$116M2.1M3.94%—New
8MELIMercadolibre Inc$99M48.1K3.34%+31.8%Added
9FCXFreeport-Mcmoran Inc$69M1.4M2.33%+19.4%Added
10FLUTFlutter Entmt Plc$62M261.0K2.09%−22.1%Trimmed
11KMIKinder Morgan Inc Del$58M2.6M1.95%−61.3%Trimmed
12PMPhilip Morris Intl Inccall option$57M472.2K1.94%−51.0%Trimmed
13TECKTeck Resources Ltd$53M1.0M1.80%−30.0%Trimmed
14VSTVistra Corp$46M391.4K1.57%−85.1%Trimmed
15AVGOBroadcom Inc$41M240.0K1.40%—New
16DFSEURDiscover Finl Svcs$40M284.9K1.35%+70.3%Added
17ASNDAscendis Pharma A/S$40M265.0K1.34%—New
18MAAMid-Amer Apt Cmntys Inc$38M238.7K1.28%−62.9%Trimmed
19CPTCamden Ppty Tr$36M290.9K1.22%−49.7%Trimmed
20DAKTDaktronics Inc$33M2.6M1.12%+3.0%Added
21WABWabtec$33M179.7K1.11%+19.2%Added
22—Nvent Electric Plc$32M451.1K1.07%—New
23—Seagate Technology Hldngs Plcall option$29M263.0K0.98%—New
24BMABanco Macro Sa$27M424.1K0.91%+55.3%Added
25TEVATeva Pharmaceutical Inds Ltd$26M1.4M0.87%—New
26BCSBarclays Plc$24M2.0M0.83%−3.3%Trimmed
27USX1United States Stl Corp$23M663.1K0.79%—New
28—Springworks Therapeutics Inc$23M705.1K0.77%−31.0%Trimmed
29GTMZoominfo Technologies Inc$22M2.1M0.75%−63.6%Trimmed
30CNMCore & Main Inc$21M475.2K0.71%—New
31CCitigroup Inc$20M327.4K0.69%—New
32VRNAVerona Pharma Plc$20M686.0K0.67%—New
33ARGTGlobal X Fds$19M282.0K0.63%0.0%Held
34MSFTMicrosoft Corp$19M43.1K0.63%−89.2%Trimmed
35ADBEAdobe Inc$18M34.5K0.61%−6.0%Trimmed
36CRNXCrinetics Pharmaceuticals In$16M309.0K0.53%0.0%Held
37—Crh Plc$15M162.5K0.51%—New
38GGALGrupo Financiero Galicia S.A$15M355.3K0.51%−25.3%Trimmed
39PANWPalo Alto Networks Inc$15M43.7K0.51%−50.9%Trimmed
40WULFTerawulf Inc$14M2.9M0.47%+40.9%Added
41TPGTpg Incput option$13M217.5K0.42%—New
42—Flex Ltd$12M348.9K0.40%−75.9%Trimmed
43CBChubb Limited$10M34.8K0.34%—New
44ADSKAutodesk Inc$10M36.4K0.34%—New
45MTBM & T Bk Corp$10M56.2K0.34%—New
46TFCTruist Finl Corp$10M233.5K0.34%—New
47TSMTaiwan Semiconductor Mfg Ltd$10M57.4K0.34%—New
48USBUs Bancorp Del$10M217.4K0.34%—New
49HBANHuntington Bancshares Inc$10M671.2K0.33%—New
50CFGCitizens Finl Group Inc$10M238.6K0.33%—New
51KEYKeycorp$10M583.9K0.33%—New
52FHNFirst Horizon Corporation$10M619.7K0.33%—New
53ABCBAmeris Bancorp$10M154.0K0.33%—New
54FCNCAFirst Ctzns Bancshares Inc N$10M5.2K0.32%—New
55YPFYpf Sociedad Anonima$9M430.1K0.31%−32.6%Trimmed
56SPRYArs Pharmaceuticals Inc$8M536.9K0.26%—New
57GEVGe Vernova Inc$7M29.3K0.25%−90.2%Trimmed
58SLNSilence Therapeutics Plc$7M387.4K0.24%0.0%Held
59ACLXGBXArcellx Inc$6M74.1K0.21%0.0%Held
60TRPTc Energy Corp$5M115.4K0.19%—New
61SBUXStarbucks Corp$5M52.3K0.17%—New
62XPOXpo Inc$5M46.5K0.17%—New
63PCVXVaxcyte Inc$5M43.0K0.17%—New
64WDCWestern Digital Corp.$5M71.4K0.17%—New
65—Newamsterdam Pharma Company$5M287.5K0.16%—New
66RAREUltragenyx Pharmaceutical In$5M85.4K0.16%—New
67BCYCBicycle Therapeutics Plc$4M190.2K0.15%0.0%Held
68ARMArm Holdings Plc$3M21.6K0.10%—New
69—Ihs Holding Limited$2M770.3K0.08%0.0%Held
70TLSITrisalus Life Sciences Inc$2M426.9K0.07%0.0%Held
71PLTRPalantir Technologies Inc$2M41.7K0.05%−94.6%Trimmed
72INSMInsmed Inc$1M20.0K0.05%0.0%Held
73NRIXNurix Therapeutics Inc$993K44.2K0.03%0.0%Held
74IVVDInvivyd Inc$583K571.4K0.02%0.0%Held
75—Joby Aviation Inc$113K22.5K0.00%0.0%Held
22 exited positions

Positions held in the preceding quarter and absent from this filing. Values and shares are from the preceding quarter.

TickerIssuerPrevious valuePrevious shares
OPCHOption Care Health Inc$52M1.9M
NVDANvidia Corporation$26M214.1K
MSGEMadison Square Garden Entmt$24M694.2K
NWSANews Corp New$19M683.8K
ANETArista Networks Inc$18M52.3K
NWSNews Corp New$18M635.9K
BAHBooz Allen Hamilton Hldg Cor$13M83.8K
IQVIqvia Hldgs Inc$13M60.4K
LYVLive Nation Entertainment In$10M103.1K
CNKCinemark Hldgs Inc$9M400.8K
VCYTVeracyte Inc$6M259.9K
AESAes Corp$6M314.8K
AAPLApple Inc$5M24.4K
SGITempur Sealy Intl Inc$5M103.1K
—Liberty Global Ltd$5M275.3K
SESea Ltd$5M66.9K
—Liberty Global Ltd$5M261.9K
EQTEqt Corp$4M121.0K
SPHRSphere Entertainment Co$4M122.4K
BLDRBuilders Firstsource Inc$4M29.4K
GPCRStructure Therapeutics Inc$1M37.7K
TEOTelecom Argentina Sa$1M143.1K
Every quarter on file (53)

From the manager’s Form 13F-HR filings on SEC EDGAR, amendments applied. Long US positions only; not a recommendation.